The effect of Pomegranate supplement on Ulcerative Colit
Phase 3
Recruiting
- Conditions
- lcerative Colit.
- Registration Number
- IRCT20200614047774N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Disease diagnosed by a Gastroenterologist
The patient's medical condition has been stable for the past two months
The desire to participate in the study
Exclusion Criteria
Sensitivity to pomegranate or its products
Pregnancy
Lactation
Taking steroid drugs, other experimental drugs, and probiotics
Kidney, heart and hepatitis
Taking other nutritional supplements
Having a special diet
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IL-6. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;IL-10. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;TNF-alpha. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;Hs-CRP. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;ANCA. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.;Fecal Calprotectin. Timepoint: The beginning and end of the study. Method of measurement: laboratory test.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: The beginning and end of the study. Method of measurement: IBDQ-9 questionaire.;Severity of symptoms. Timepoint: The beginning and end of the study. Method of measurement: SCCAI questionair.;Antropometric Index. Timepoint: The beginning and end of the study. Method of measurement: Body measurement.